• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical aspects of indocyanine green pharmacokinetics following portal vein administration.门静脉给药后吲哚菁绿药代动力学的临床研究
Br J Clin Pharmacol. 1998 Jan;45(1):41-7. doi: 10.1046/j.1365-2125.1998.00641.x.
2
Experimental study of liver dysfunction evaluated by direct indocyanine green clearance using near infrared spectroscopy.使用近红外光谱法通过直接吲哚菁绿清除率评估肝功能障碍的实验研究
Br J Surg. 1999 Aug;86(8):1005-11. doi: 10.1046/j.1365-2168.1999.01186.x.
3
Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model.肝血流和功能对肝硬化动物模型中直接测量的肝脏吲哚菁绿清除率的影响。
Br J Surg. 2000 May;87(5):568-74. doi: 10.1046/j.1365-2168.2000.01399.x.
4
Intraoperative simulation of remnant liver function during anatomic liver resection with indocyanine green clearance (LiMON) measurements.在解剖性肝切除术中通过吲哚菁绿清除率(LiMON)测量对残余肝功能进行术中模拟。
HPB (Oxford). 2015 Jun;17(6):471-6. doi: 10.1111/hpb.12380. Epub 2015 Jan 8.
5
Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.吲哚菁绿滞留试验(ICG-r15)作为不同严重程度肝硬化患者门静脉高压的无创预测指标。
Eur J Gastroenterol Hepatol. 2016 Aug;28(8):948-54. doi: 10.1097/MEG.0000000000000611.
6
Preoperative assessment of liver function.肝功能的术前评估。
Surg Clin North Am. 2004 Apr;84(2):355-73. doi: 10.1016/S0039-6109(03)00224-X.
7
Evaluation of a transcutaneous method to assess canine liver function by indocyanine green plasma disappearance rate in healthy adult Beagle dogs.通过吲哚菁绿血浆消失率评估经皮方法对健康成年比格犬肝功能的研究
Vet J. 2016 Mar;209:169-73. doi: 10.1016/j.tvjl.2015.10.053. Epub 2015 Nov 2.
8
The influence of nifedipine and captopril on liver blood flow in healthy subjects.硝苯地平和卡托普利对健康受试者肝血流量的影响。
Br J Clin Pharmacol. 1998 May;45(5):447-51. doi: 10.1046/j.1365-2125.1998.00709.x.
9
Effects of different positive end-expiratory pressure values on liver function and indocyanine green clearance test in liver transplantation donors: a prospective, randomized, double-blind study.不同呼气末正压值对肝移植供体肝功能及吲哚菁绿清除试验的影响:一项前瞻性、随机、双盲研究
Transplant Proc. 2015 May;47(4):1190-3. doi: 10.1016/j.transproceed.2015.01.028.
10
Future Liver Remnant Indocyanine Green Plasma Clearance Rate as a Predictor of Post-hepatectomy Liver Failure After Portal Vein Embolization.未来肝剩余体积的吲哚菁绿血浆清除率作为门静脉栓塞后门静脉栓塞术后肝衰竭的预测指标。
Cardiovasc Intervent Radiol. 2018 Dec;41(12):1877-1884. doi: 10.1007/s00270-018-2065-2. Epub 2018 Aug 21.

本文引用的文献

1
Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.静脉推注和持续输注后完整猪体内吲哚菁绿的血浆清除:分光光度法和高压液相色谱法用于浓度分析的比较
Hepatology. 1993 Dec;18(6):1504-15.
2
Comparison of the effects of sevoflurane, isoflurane and halothane on indocyanine green clearance.七氟烷、异氟烷和氟烷对吲哚菁绿清除率影响的比较。
Br J Anaesth. 1995 Feb;74(2):164-7. doi: 10.1093/bja/74.2.164.
3
Determinants of drug disposition in patients with cirrhosis.肝硬化患者药物处置的决定因素。
Hepatology. 1983 Nov-Dec;3(6):913-8. doi: 10.1002/hep.1840030604.
4
Effects of combined extradural blockade and general anaesthesia on indocyanine green clearance and halothane metabolism.硬膜外阻滞与全身麻醉联合应用对吲哚菁绿清除率及氟烷代谢的影响。
Br J Anaesth. 1986 Jan;58(1):29-36. doi: 10.1093/bja/58.1.29.
5
A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.肝脏消除的弥散模型:1. 模型的建立及大剂量注射的考量
J Pharmacokinet Biopharm. 1986 Jun;14(3):227-60. doi: 10.1007/BF01106706.
6
Clearance approaches in pharmacology.药理学中的清除方法。
Pharmacol Rev. 1987 Mar;39(1):1-47.
7
Experimental impact of assay-dependent differences in plasma indocyanine green concentration determinations.血浆吲哚菁绿浓度测定中分析方法依赖性差异的实验影响
J Pharmacokinet Biopharm. 1987 Dec;15(6):601-13. doi: 10.1007/BF01068415.
8
Methodological limitations of the use of intrinsic hepatic clearance of ICG as a measure of liver cell function.
Eur J Clin Invest. 1988 Oct;18(5):507-11. doi: 10.1111/j.1365-2362.1988.tb01048.x.
9
Monitoring hepatic venous hemoglobin oxygen saturation in patients undergoing liver surgery.
Anesthesiology. 1991 Jan;74(1):49-52. doi: 10.1097/00000542-199101000-00009.
10
Circadian changes in estimated hepatic blood flow in healthy subjects.健康受试者肝脏血流估计值的昼夜节律变化。
Br J Clin Pharmacol. 1991 Nov;32(5):627-9. doi: 10.1111/j.1365-2125.1991.tb03964.x.

门静脉给药后吲哚菁绿药代动力学的临床研究

Clinical aspects of indocyanine green pharmacokinetics following portal vein administration.

作者信息

Nishi S, Shindo M, Abe J, Asada A

机构信息

Department of Anesthesiology and Intensive Care Medicine, Osaka City University Medical School, Osaka, Japan.

出版信息

Br J Clin Pharmacol. 1998 Jan;45(1):41-7. doi: 10.1046/j.1365-2125.1998.00641.x.

DOI:10.1046/j.1365-2125.1998.00641.x
PMID:9489593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1873989/
Abstract

AIMS

This study was performed to demonstrate that measurement of the clearance of indocyanine green (ICG) following portal vein administration (CLpv) is more useful than that following peripheral vein administration (CLiv) for evaluating intrinsic clearance and hepatic blood flow.

METHODS

Eight patients, aged 55.9 +/- 8.8 years, who underwent partial hepatectomy were studied. ICG was administrated to all patients via peripheral and portal veins before and after enflurane anaesthesia and soon after surgery. ICG concentrations were measured by h.p.l.c. Non-compartmental analysis was applied to the ICG time-concentration data obtained. The area under the curve (AUC), clearance (CL), mean residence time (MRT) and volume of distribution (V) were calculated using this method of analysis.

RESULTS

CLpv was significantly decreased from 26.4 +/- 13.2 ml kg(-1) min(-1) before anaesthesia, to 19.5 +/- 7.0 (P < 0.05) and 12.7 +/- 5.3 (P < 0.01) ml kg(-1) min(-1), respectively, during anaesthesia and after partial hepatectomy; These values were 72.1% (P < 0.01) and 48.5% (P < 0.01) of that observed at percutaneous transhepatic portography (PTP). CLiv was significantly decreased from 14.6 +/- 5.3 ml kg(-1) min(-1) before anaesthesia, to 9.4 +/- 3.6 (P < 0.05) and 9.8 +/- 4.1 (P < 0.05) ml kg(-1) min(-1), respectively, after partial hepatectomy and 12 h after operation; These values were 68.9% (P < 0.05) and 73.5% (P < 0.05) of the value at PTP. The other pharmacokinetic parameters examined, V and MRT, did not change significantly during anaesthesia or after surgery.

CONCLUSION

The clearance of ICG after portal administration was useful for estimating hepatic blood flow and intrinsic clearance in perioperative management of liver surgery.

摘要

目的

本研究旨在证明,对于评估肝固有清除率和肝血流量,门静脉给药后吲哚菁绿(ICG)清除率(CLpv)的测量比外周静脉给药后(CLiv)更有用。

方法

对8例年龄为55.9±8.8岁、接受部分肝切除术的患者进行研究。在恩氟烷麻醉前后及手术后不久,通过外周静脉和门静脉给所有患者注射ICG。采用高效液相色谱法测定ICG浓度。对获得的ICG时间-浓度数据进行非房室分析。使用该分析方法计算曲线下面积(AUC)、清除率(CL)、平均驻留时间(MRT)和分布容积(V)。

结果

CLpv从麻醉前的26.4±13.2 ml·kg⁻¹·min⁻¹显著降低至麻醉期间的19.5±7.0(P<0.05)和部分肝切除术后的12.7±5.3(P<0.01)ml·kg⁻¹·min⁻¹;这些值分别为经皮经肝门静脉造影术(PTP)时观察值的72.1%(P<0.01)和48.5%(P<0.01)。CLiv从麻醉前的14.6±5.3 ml·kg⁻¹·min⁻¹显著降低至部分肝切除术后的9.4±3.6(P<0.05)和术后12小时的9.8±4.1(P<0.05)ml·kg⁻¹·min⁻¹;这些值分别为PTP时值的68.9%(P<0.05)和73.5%(P<0.05)。所检查的其他药代动力学参数,V和MRT,在麻醉期间或手术后无显著变化。

结论

门静脉给药后ICG的清除率有助于估计肝血流和肝固有清除率,用于肝脏手术围手术期管理。